Latest 8-K filings

First Community Corporation announced the appointment of Terrance Ford and Shell K. Berry to its board of directors, bringing expertise in technology, cybersecurity, and investment banking.

USBC, Inc. has entered into an unsecured promissory note with Goldeneye 1995 LLC, an entity solely owned by its CEO, for up to $22.0 million to fund general corporate and working capital needs.

Capstone Holding Corp. announced preliminary July-August 2026 results, showing 7.6% organic revenue growth and 6.5% organic gross profit growth, demonstrating continued momentum.

VirnetX Holding Corporation has entered into an At the Market Offering Agreement to sell up to $19,135,717 of its common stock to fund product development, marketing, and general corporate purposes.

AMC Robotics Corporation announced the appointment of Dr. Ang Li, an AI and machine learning expert, as its new Chief Technology Officer to drive advancements in autonomous intelligence and AI-powered robotics.

Our Bond, Inc. reports positive sales pipeline indicators post-GSX 2026 and announces a 1-for-20 reverse stock split approved by the board and shareholders.

Vir Biotechnology announces the appointment of Aziz Sawaf as its new Executive Vice President and Chief Financial Officer, effective October 5, 2026.

Agassi Sports Entertainment Corp. has established a new wholly-owned subsidiary, Lets Play, LLC, to build a global network of racket sports facilities and appointed Jonathan Fornaci as its President.

CION Investment Corporation announced it will report its third quarter 2026 financial results on November 5, 2026, followed by an investor conference call.

AVAX One Technology Ltd. announced a significant increase in its share repurchase volume for September 2026, repurchasing 333,500 shares under its $40 million program.

Battalion Oil Corporation announced the appointment of John Brad Juneau to its Board of Directors, expanding the board to five members and reinforcing its commitment to a majority-independent board.

Lifeward Ltd. announces interim CFO appointment as part of ongoing executive transitions, with a permanent CFO set to join in November.

Evolution Metals & Technologies Corp. (EM&T) and VIVIFY Technology Corporation have signed a non-binding letter of intent for VIVIFY to provide behind-the-meter hydrogen power for EM&T's planned U.S. rare earth magnet campus.

America's Car-Mart has obtained a short-term extension on loan waivers and liquidity thresholds through October 8, 2026, while continuing its strategic alternatives review.

NSTS Bancorp, Inc. has finalized its merger with Brookfield Bancshares, Inc., with shareholders receiving $14.31 per share.

Minerals Technologies Inc. announced a private offering of $400 million in senior notes due 2034 to redeem existing debt and cover related expenses.

Casella Waste Systems announced an earlier-than-expected closure date for its North Country Environmental Services landfill, leading to increased amortization expenses.

Banzai International, Inc. reports its CEO, Joseph Davy, purchased 115,965 shares of Class B Common Stock for $81,176, maintaining a significant voting interest.

Omega Healthcare Investors announces CEO transition with President Matthew P. Gourmand succeeding C. Taylor Pickett, who retires.

BNB Plus Corp. has entered into a second amendment to its Registration Rights Agreement, altering the terms for filing registration statements for certain securities.

The Federal Circuit has remanded ParkerVision's patent infringement case against Qualcomm back to the district court, dismissing the appeal for lack of jurisdiction and allowing the company to pursue a jury trial for transmitter patent claims.

SpyGlass Pharma has acquired Advanced Vision Science, Inc. (AVS) for approximately $13 million, securing scalable commercial intraocular lens (IOL) manufacturing and accelerating its drug delivery system expansion.

Orchestra BioMed Holdings, Inc. announced it has exceeded its enrollment target for the BACKBEAT Global Pivotal Trial of AVIM Therapy, a significant milestone in its collaboration with Medtronic.

Corteva, Inc. has successfully completed the separation of its seed operating segment into a new independent, publicly traded company named Vylor Inc.

Corteva, Inc. has successfully completed the separation of its seed operating segment into a new independent, publicly traded company named Vylor Inc.

First Merchants Corporation announced the upcoming retirement of CEO Mark Hardwick, effective January 1, 2027, with President Mike Stewart set to assume the CEO role.

Azitra, Inc. announced its Phase 1/2 clinical trial for ATR-04 in treating EGFR inhibitor-associated skin rash will proceed to Cohort 2 following a positive safety review.

Aptera Motors announced a substantial reduction in its estimated capital requirements for production, driven by a strategic partnership with Launch Design.

Airgain, Inc. announced the appointment of Stephan D. Memmen to its Board of Directors, effective October 1, 2026, expanding the board to eight members.

Evommune presented compelling Phase 2a data for EVO301 in atopic dermatitis, demonstrating significant efficacy and a favorable safety profile, with plans for a Phase 2b trial in mid-2027.